Sectors

ADMA
ADMA Biologics, Inc.
8.63
6 x 8.62
5 x 8.63
bid
ask
+
0.04
0.41%
10:01 AM
timesize
Ytd-52.71%
1y-49.41%
8.57
day range
8.68
7.21
52 week range
20.46
Open8.59Prev Close8.59Low8.57High8.68Mkt Cap1.99B
Vol151.15KAvg Vol4.59MEPS0.70P/E12.27Forward P/E10.50
Beta0.73Short Ratio6.48Inst. Own93.59%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg8.46200-d Avg13.581yr Est17.00

ADMA News

ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
globenewswire.com
ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTIO

NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor

ADMA Court Alert: ADMA Biologics Investors Seeking to Recover Losses in Securities Fraud Class Action are Notified to Contact BFA Law before August 10 Deadline
globenewswire.com
ADMA Court Alert: ADMA Biologics Investors Seeking to Recover Losses in Securities Fraud Class Actio

NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
globenewswire.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

NEW YORK and NEW ORLEANS, July 21, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF p

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note
zacks.com
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note

The latest trading day saw Adma Biologics (ADMA) settling at $8.59, representing a -1.83% change fro

ROSEN, LEADING INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA
newsfilecorp.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before

New York, New York--(Newsfile Corp. - July 21, 2026) - WHY: Rosen Law Firm, a global investor rights

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologi

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
gurufocus.com
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud La

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud La

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud La

BENSALEM, Pa., July 21, 2026 /PRNewswire/ -- The Law Offices of Howard G.

Portnoy Law Firm Announces Class Action on Behalf of ADMA Biologics, Inc. Investors
globenewswire.com
Portnoy Law Firm Announces Class Action on Behalf of ADMA Biologics, Inc. Investors

LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ADMA Biologics, Inc., (“

ADMA UPCOMING DEADLINE: SueWallSt Alerts ADMA BIOLOGICS, INC. Stockholders of Securities Class Action
globenewswire.com
ADMA UPCOMING DEADLINE: SueWallSt Alerts ADMA BIOLOGICS, INC. Stockholders of Securities Class Actio

Wall Street's reassessment of ADMA Biologics accelerated after a short-seller report alleged that th

ADMA DEADLINE: The Gross Law Firm Reminds ADMA Biologics, Inc. Investors of Upcoming Securities Class Action Deadline
prnewswire.com
ADMA DEADLINE: The Gross Law Firm Reminds ADMA Biologics, Inc. Investors of Upcoming Securities Clas

NEW YORK, July 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholde

ADMA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
newsfilecorp.com
ADMA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Ac

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

ADMA Lawsuit Notice: ADMA Biologics Channel Stuffing Allegations and 29% Stock Drop Trigger Securities Fraud Class Action
prnewswire.com
ADMA Lawsuit Notice: ADMA Biologics Channel Stuffing Allegations and 29% Stock Drop Trigger Securiti

A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after i

INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead ADMA Investor Class Action Lawsuit – RGRD Law
globenewswire.com
INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to

SAN DIEGO, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announ

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti,

ADMA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA
newsfilecorp.com
ADMA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Lo

New York, New York--(Newsfile Corp. - July 20, 2026) - WHY: Rosen Law Firm, a global investor rights

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schal

LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
feeds.newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Al

New York, New York--(Newsfile Corp. - July 20, 2026) - Bronstein, Gewirtz and Grossman, LLC, a natio

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Al

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogni

ADMA Shareholder Alert: ADMA BIOLOGICS, INC. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
globenewswire.com
ADMA Shareholder Alert: ADMA BIOLOGICS, INC. Securities Class Action Lawsuit - Investors Should Cont

ADMA Biologics' SEC filings allegedly used boilerplate risk language and selective related party dis

$ADMA Legal News: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securities Fraud Class Action – Investors Notified to Contact BFA Law
globenewswire.com
$ADMA Legal News: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securiti

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a

ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
prnewswire.com
ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your

LOS ANGELES, July 20, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action law

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
gurufocus.com
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schal

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schal

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schal

LOS ANGELES, July 20, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litiga

ADMA CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
newsfilecorp.com
ADMA CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA
globenewswire.com
ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to

NEW YORK, July 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA
newsfilecorp.com
ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors

New York, New York--(Newsfile Corp. - July 18, 2026) - WHY: Rosen Law Firm, a global investor rights

ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
gurufocus.com
ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit

ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
gurufocus.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
prnewswire.com
ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit

NEW YORK, July 17, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, rem

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
prnewswire.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

/PRNewswire/ -- Kahn Swick and Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisia

ADMA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
newsfilecorp.com
ADMA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Actio

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 17, 2026) - Kahn Swick & Foti,

Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com
Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Glancy Pron

LOS ANGELES, July 17, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o

ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information About the Class Action Against ADMA Biologics, Inc.
businesswire.com
ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information Abo

SAN DIEGO--(BUSINESS WIRE)---- $ADMA #Biopharmaceutical--Robbins LLP reminds stockholders that a cla

ADMA UPCOMING DEADLINE : The Gross Law Firm Alerts ADMA Biologics, Inc. Stockholders of Securities Class Action - Contact the Firm
globenewswire.com
ADMA UPCOMING DEADLINE : The Gross Law Firm Alerts ADMA Biologics, Inc. Stockholders of Securities C

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareh

ADMA Legal Deadline Notice: Important ADMA Biologics Deadline in Securities Fraud Class Action is Approaching – Investors Notified to Contact BFA Law by August 10
globenewswire.com
ADMA Legal Deadline Notice: Important ADMA Biologics Deadline in Securities Fraud Class Action is Ap

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a

ADMA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead ADMA Biologics Class Action Lawsuit
prnewswire.com
ADMA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investo

SAN DIEGO, July 17, 2026 /PRNewswire/ --  Robbins Geller Rudman & Dowd LLP announces that purchasers

INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
newsfilecorp.com
INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to

San Diego, California--(Newsfile Corp. - July 16, 2026) - Robbins Geller Rudman & Dowd LLP announces

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA
globenewswire.com
ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses i

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

NASDAQ: ADMA CLASS ACTION NOTICE: Berger Montague Encourages ADMA Biologics, Inc. (NASDAQ: ADMA) Investors to Inquire About a Securities Fraud Class Action
prnewswire.com
NASDAQ: ADMA CLASS ACTION NOTICE: Berger Montague Encourages ADMA Biologics, Inc. (NASDAQ: ADMA) Inv

PHILADELPHIA, July 16, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announc

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
feeds.newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Al

New York, New York--(Newsfile Corp. - July 16, 2026) - Bronstein, Gewirtz and Grossman, LLC, a natio

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Al

New class action for ADMA Biologics (ADMA) urges investors to seek recovery for alleged securities f

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
globenewswire.com
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of

NEW ORLEANS, July 16, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service,

ADMA DEADLINE: SueWallSt Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline
prnewswire.com
ADMA DEADLINE: SueWallSt Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action

ADMA Biologics allegedly certified internal controls as effective while concealing channel stuffing

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines - ADMA
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologi

NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)
globenewswire.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has

ADMA Fraud Notice: ADMA Biologics Investors are Reminded to Contact BFA Law about the Filed Securities Fraud Class Action Lawsuit to Recover Investment Losses
businesswire.com
ADMA Fraud Notice: ADMA Biologics Investors are Reminded to Contact BFA Law about the Filed Securiti

NEW YORK--(BUSINESS WIRE)---- $ADMA #ADMA--ADMA Biologics Investors are Reminded to Contact BFA Law

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud La

LOS ANGELES, July 15, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investor

benzinga.com
Mizuho Maintains Outperform on ADMA Biologics, Lowers Price Target to $17

Mizuho analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Outperform and lower